Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors ; volume:14 ; number:1 ; day:3 ; month:11 ; year:2023 ; pages:1-16 ; date:12.2023
Nature Communications ; 14, Heft 1 (3.11.2023), 1-16, 12.2023
- Urheber
-
Chiaro, Jacopo
Antignani, Gabriella
Feola, Sara
Feodoroff, Michaela
Martins, Beatriz
Cojoc, Hanne
Russo, Salvatore
Fusciello, Manlio
Hamdan, Firas
Ferrari, Valentina
Ciampi, Daniele
Ilonen, Ilkka
Räsänen, Jari
Mäyränpää, Mikko
Partanen, Jukka
Koskela, Satu
Honkanen, Jarno
Halonen, Jussi
Kuryk, Lukasz
Rescigno, Maria
Grönholm, Mikaela
Branca, Rui M.
Lehtiö, Janne
Cerullo, Vincenzo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-42668-7
- URN
-
urn:nbn:de:101:1-2024012212142633171723
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chiaro, Jacopo
- Antignani, Gabriella
- Feola, Sara
- Feodoroff, Michaela
- Martins, Beatriz
- Cojoc, Hanne
- Russo, Salvatore
- Fusciello, Manlio
- Hamdan, Firas
- Ferrari, Valentina
- Ciampi, Daniele
- Ilonen, Ilkka
- Räsänen, Jari
- Mäyränpää, Mikko
- Partanen, Jukka
- Koskela, Satu
- Honkanen, Jarno
- Halonen, Jussi
- Kuryk, Lukasz
- Rescigno, Maria
- Grönholm, Mikaela
- Branca, Rui M.
- Lehtiö, Janne
- Cerullo, Vincenzo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Malignant mesothelioma
Malignant mesothelioma
Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines
Recent Advances in Mesothelioma
Malignant mesothelioma in construction workers: the Apulia regional mesothelioma register, Southern Italy
Epithelioid pleural mesothelioma successfully treated with perioperative immunotherapy: a case report
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy
Atypical presentation of testicular mesothelioma
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line
Malignant mesothelioma
Malignant mesothelioma
Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines
Recent Advances in Mesothelioma
Malignant mesothelioma in construction workers: the Apulia regional mesothelioma register, Southern Italy
Epithelioid pleural mesothelioma successfully treated with perioperative immunotherapy: a case report
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy
Atypical presentation of testicular mesothelioma
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line
Malignant mesothelioma
Malignant mesothelioma
Cytogenomic characterization of three murine malignant mesothelioma tumor cell lines
Recent Advances in Mesothelioma
Malignant mesothelioma in construction workers: the Apulia regional mesothelioma register, Southern Italy
Epithelioid pleural mesothelioma successfully treated with perioperative immunotherapy: a case report
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
Assessment of new HDAC inhibitors for immunotherapy of malignant pleural mesothelioma
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy
Atypical presentation of testicular mesothelioma
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma